Wednesday, January 19, 2022
News for Retirees


High 5 Most-Learn Medicare Articles of 2021

Share this…FacebookPinterestTwitterLinkedin This 12 months’s most-read articles on Medicare lined subjects together with accountable care organizations, value-based cost, and star…

By Staff , in Medicare , at December 25, 2021



This 12 months’s most-read articles on Medicare lined subjects together with accountable care organizations, value-based cost, and star scores.

The highest 5 most-read Medicare tales of 2021 on AJMC.com centered on star score will increase, value-based cost concepts, and the dangers of polypharmacy. Additionally they explored the worth impacts of accountable care organizations (ACOs) and the ramifications of the FDA’s approval of an Alzheimer illness drug.

Listed below are the highest 5 most-read Medicare articles of 2021.

5. Softer Alignment of Medicare ACOs Could Nonetheless Result in Larger Costs for Workplace Visits

What occurs to well being care costs when practices align in ACOs as a substitute of outright mergers or acquisitions? This text from June lined the findings of a research that investigated this query and located that practices becoming a member of well being system–led ACOs noticed a mean of 4% greater costs. The research authors cautioned that these preparations might warrant nearer monitoring.

Learn the total article.

4. Most MA Plans in Annual CMS Report See Star Scores Improve

The variety of Medicare Benefit (MA) plans receiving a 5-star score from CMS elevated to 87 for the 2022 efficiency 12 months, in keeping with this October article overlaying a reality sheet launched by CMS. Of notice, 11 high quality measures noticed will increase because the 12 months prior, however most measures declined, owing to the consequences of the COVID-19 pandemic. CMS additionally mentioned that plans provided by nonprofit organizations are inclined to earn greater scores than these from for-profit corporations.

Learn the total article.

3. Biden Administration Drug Plan Consists of Worth-Based mostly Fee Concepts for Medicare

This text lined the plan to cut back prescription drug costs that was launched by the Biden administration in September. The plan consists of using fashions to check value-based funds in Medicare Half B, and another tenets embrace promotion of biosimilars and worth negotiation with producers. Specifically, it urged using shared financial savings fashions by which Half B financial savings from utilizing biosimilars or generics could be shared between the federal government and the prescribing suppliers.

Learn the total article.

2. How Biogen’s Aduhelm Approval Marks a Precipitous Turning Level for the FDA

This text from July took a deep dive into the controversies surrounding the FDA’s approval of Biogen’s aducanumab (Aduhelm) for Alzheimer illness in June. The drug’s route by an accelerated approval course of and contradictory proof of efficacy might jeopardize the general public’s belief within the FDA at a vital time, and a few clinicians interviewed by AJMC.com mentioned they might be hesitant to prescribe it. The article famous that CMS has begun an evaluation to find out whether or not Medicare can have a nationwide protection coverage for aducanumab, which is projected to price $56,000 for 1 12 months of therapy.

Learn the total article.

1. Polypharmacy Linked to Larger Danger of Hospital Readmission

Polypharmacy, or taking 5 or extra prescriptions per day, was related to the next threat of 30-day hospital readmission, in keeping with research findings that we lined in July. In analyzing the chance of readmission, investigators discovered that polypharmacy had an odds ratio (OR) of 1.043 for every extra drug prescribed, which was greater than the OR for size of keep (1.014 per extra keep). Sure medication, resembling antiemetics and antinauseants, had a stronger hyperlink with readmission than others. The research authors famous that the drivers of hospital readmissions needs to be additional investigated in predictive analysis.

Learn the total article.



Source link

Skip to content